MedTrace Logo

A Comparison of Photorefractive Keratectomy (PRK), PRK With Mitomycin-C and Laser Subepithelial Keratomileusis (LASEK) in the Treatment of Moderate and High Myopia

NCT00415077 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 960

Last updated 2010-07-16

No results posted yet for this study

Summary

The purpose of this study is to assess whether there is a significant difference in visual outcomes or corneal haze after surface ablation for moderate and high myopia in active duty service members treated with PRK, Mitomycin-C (MMC) PRK and LASEK.

Conditions

  • MODERATE AND HIGH MYOPIA

Interventions

PROCEDURE

PRK

PRK

PROCEDURE

MMC PRK

mitomycin C PRK

PROCEDURE

LASEK

LASEK

Sponsors & Collaborators

  • Madigan Army Medical Center

    collaborator FED

  • C.R.Darnall Army Medical Center

    collaborator FED

  • Blanchfield Army Community Hospital

    collaborator FED

  • Tripler Army Medical Center

    collaborator FED

  • Walter Reed Army Medical Center

    lead FED

Principal Investigators

  • KRAIG S BOWER, MD · DIRECTOR, CENTER FOR REFRACTIVE SURGERY WALTER REED ARMY MEDICAL CENTER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00415077 on ClinicalTrials.gov